ISPOR Offering Short Courses on Value Assessment Frameworks, HTA
The International Society of Pharmacoeconomics and Outcomes Research (ISPOR) is offering two short, online courses. Below are the two courses: [...]
Study: ICER Reports Play Major Role in MCOs’ Decisions
Many managed care organizations say they use reports by the Institute for Clinical and Economic Review (ICER) in their decision-making, [...]
ICON’s Row, Capobianco and Adamski Talk Increasing Participation in Real-World Studies
In a recent interview with PMLiVE, ICON plc's Bill Row, Bruce Capobianco and Maggie Adamski discussed ways to increase patient [...]
Guidehouse’s Austin Talks Waste in Supply Chain
Guidehouse Health Systems Director Rob Austin in a new Relentless Health Value podcast discusses the financial waste produced by mismanaged [...]
Blog Post Urges Greater Understanding of Patient Experience Regarding De-implementation
A recent blog post on AcademyHealth says it is imperative to further study how patients deal with de-implementation. The authors, [...]
Giri, Patel: Tough Road Ahead for Payers in Post-COVID Landscape
A recent article published in Managed Healthcare Executive looks at several key challenges payers will have to face in the [...]
eBook Looks at How Providers, Payers Drive Outcomes-Based Analytics
A new report from Snowflake looks at how its cloud data solution and Tableau help providers and payers manage large, [...]
AcademyHealth’s Virtual Annual Research Meeting Nears
AcademyHealth's Annual Research Meeting is still on track to deliver the much-anticipated suite of offerings in a virtual environment. Set [...]
Study: Zero Co-Pay Program Reduced Health Spending by 18%
Blue Cross Blue Shield of Louisiana's (BCBSLA) Zero Dollar Co-pay (ZDC) program cut total, per-month health care spending by 18 [...]
New JCP Series Looks at Progress of Clinical Pathways
A new series by the Journal of Clinical Pathways offers insight from board members on the growth of clinical pathways. [...]
Jeff Anderson Joins OPEN Health as European Lead for OPEN VIE and Pharmerit
Via Pharmerit OPEN Health, the family of expert practices working in partnership to drive positive change in healthcare communications and [...]
Xcenda Report Highlights Digital Health Tech, Gene Therapies for Hemophilia
Xcenda's latest HTA Quarterly report shifts the spotlight to digital health technology, gene therapies for hemophilia and the EU's new [...]
ISPOR Europe 2020 Deadline for Abstract Submissions Nears
The abstract submission deadline for ISPOR's upcoming European meeting is July 8. ISPOR 2020 Europe is set to kick off [...]
Researchers Support Targeted Population Health Interventions to Boost COVID-19 Outcomes
Health care systems should target population health interventions to patients with existing chronic diseases to bolster COVID-19 outcomes, researchers in [...]
Virtual ISPOR Session Offers Health Policy Insights
Speakers during the first plenary session of the Virtual ISPOR 2020 event offered expert insights into health policy from the [...]
Where Epidemiologists are Leaning on Kids Returning to School
A recent New York Times Upshot article offers comments from 133 epidemiologists on the matter of children returning to school [...]
Report: World ‘on the Precipice of a New Age of Medicine’
As the COVID-19 pandemic spurs a greater desire for more robust data, the "world is on the precipice of a [...]
ISPOR Conducting Survey Regarding OSMs
An International Society for Pharmacoeconomics and Outcomes Research (ISPOR) special interest group is conducting a survey to gauge opinions on [...]
Report: Drugmakers Engaging in ‘Science by Press Release’
Drugmakers are increasingly taking up a tactic to make their experimental products stand out, according to a Politico report: "science [...]
ICER Plans Review of Treatments for High Cholesterol
The Institute for Clinical and Economic Review (ICER) announced plans to review Novartis' inclisiran and Esperion Therapeutics' Nexletol for the [...]
Phesi President Talks Impact of Pandemic on Trials, Supports Data-Driven Approach
Phesi Founder and President Gen Li in a recent interview with Outsourcing-Pharma discussed how the COVID-19 pandemic is affecting clinical [...]
Pfizer CEO Says No ‘Huge Price’ Tag on Vaccine
Pfizer CEO Albert Bourla vowed the company would not "go huge prices" on a coronavirus vaccine, Axios reports. "If we [...]
ICER to CF Community: ‘We Support Actions to Receive Fair Prices’
The Institute for Clinical and Economic Review (ICER) in a letter to the cystic fibrosis community says it supports fair [...]
Startup PatientPing Secures $60 Million in Funding
PatientPing, a Boston-based startup, secured a $60 million round of funding co-led by Andreessen Horowitz, F-Prime Capital, GV and Transformation [...]
How Can Pharma Best Interact with ICER?
A new report from FirstWord looks at how pharma can best engage with the Institute for Clinical and Economic Review [...]